You just read:

Phoenix Tissue Repair Doses First Patient in Phase 1/2 Clinical Trial of PTR-01 (BBP-589) for Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)

News provided by

Phoenix Tissue Repair, Inc.

Feb 22, 2019, 08:00 ET